News
SYRS
0.0005
NaN%
--
Weekly Report: what happened at SYRS last week (1027-1031)?
Weekly Report · 4d ago
Weekly Report: what happened at SYRS last week (1020-1024)?
Weekly Report · 10/27 09:52
Six new option listings and option delistings on October 20th
TipRanks · 10/20 12:30
Weekly Report: what happened at SYRS last week (1013-1017)?
Weekly Report · 10/20 09:50
Weekly Report: what happened at SYRS last week (1006-1010)?
Weekly Report · 10/13 09:52
Weekly Report: what happened at SYRS last week (0929-1003)?
Weekly Report · 10/06 09:50
Weekly Report: what happened at SYRS last week (0922-0926)?
Weekly Report · 09/29 09:50
Weekly Report: what happened at SYRS last week (0915-0919)?
Weekly Report · 09/22 09:50
Weekly Report: what happened at SYRS last week (0908-0912)?
Weekly Report · 09/15 09:01
Weekly Report: what happened at SYRS last week (0901-0905)?
Weekly Report · 09/08 09:01
Weekly Report: what happened at SYRS last week (0825-0829)?
Weekly Report · 09/01 09:01
Weekly Report: what happened at SYRS last week (0818-0822)?
Weekly Report · 08/25 09:01
Weekly Report: what happened at SYRS last week (0811-0815)?
Weekly Report · 08/18 09:01
Weekly Report: what happened at SYRS last week (0804-0808)?
Weekly Report · 08/11 09:01
Weekly Report: what happened at SYRS last week (0728-0801)?
Weekly Report · 08/04 09:01
Weekly Report: what happened at SYRS last week (0721-0725)?
Weekly Report · 07/28 09:01
Weekly Report: what happened at SYRS last week (0714-0718)?
Weekly Report · 07/21 09:01
Weekly Report: what happened at SYRS last week (0707-0711)?
Weekly Report · 07/14 09:01
Weekly Report: what happened at SYRS last week (0630-0704)?
Weekly Report · 07/07 09:01
Weekly Report: what happened at SYRS last week (0623-0627)?
Weekly Report · 06/30 09:01
More
Webull provides a variety of real-time SYRS stock news. You can receive the latest news about Syros Pharmaceut through multiple platforms. This information may help you make smarter investment decisions.
About SYRS
Syros Pharmaceuticals, Inc. is not engaged in any business activities. The Company is actively engaged in the voluntary delisting process. The Company was previously engaged in developing new standards of care for the frontline treatment of patients with hematologic malignancies.